115. The Future of Therapy Is Psychedelic

She might not be a household name, but Suzanne Gluck is one of the most powerful people in the book industry. Her slush pile is a key entry point to the biggest publishers in the U.S., and the authors she represents have sold more than 100 million books worldwide. Steve Levitt ta ...  Show more

He’s been an engineer, a surgeon, a management consultant, and even a boxer. Now he’s a physician focused on the science of longevity. Peter Attia talks with Steve Levitt about the problem with immortality, what’s missing from our Covid response, and why nicotine is underrated. T ...  Show more

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ...  Show more

Professor Paul Gilbert is a Clinical Psychologist at the University of Derby and honorary visiting Prof at the University of Queensland. He retired from the NHS in 2016 after over 40 years as a Consultant Clinical Psychologist. He has researched evolutionary approaches to psychop ...  Show more

How can you summon courage when you’re terrified? Is hiking more dangerous than skiing? And what is the stupidest thing that Mike has ever done?

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers psychedelic-assisted psychotherapy with Dr Emma Hapke and Dr Daniel Rosenbaum, both of whom are psychiatrists at the University Health Network in Toronto and co-founders of U ...  Show more